Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 3
Submit an article Journal homepage
92
Views
23
CrossRef citations to date
0
Altmetric
Review

Therapeutic options in mantle cell lymphoma

Saar Gill Department of Haematology and Medical Oncology, Peter MacCallum Cancer CentreCorrespondence[email protected]
&
David Ritchie Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre; Department of Clinical Haematology and Bone Marrow Transplant Service, The Royal Melbourne Hospital, Melbourne, Australia
Pages 398-409 | Received 21 Oct 2007, Accepted 06 Dec 2007, Published online: 01 Jul 2009
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Abstract

Mantle cell lymphoma (MCL) is an aggressive lymphoma requiring intensive chemotherapy ± autologous stem cell transplantation (SCT) to achieve optimal rates of progression-free survival. Here we review the treatment options for patients with newly-diagnosed or relapsed MCL and discuss recent advances in management, including the role of autologous and allogeneic SCT.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.